Almac

Almac, ESMS Global collaborate

Monday, November 24, 2014

Almac, a global provider of advanced clinical technology and support services, and ESMS, a 24/7 medical emergency response service for clinical trials based in the U.K., are collaborating to offer clients an exclusive solution surrounding emergency unblinding procedures.

[Read More]

Almac Group to expand, create 348 new jobs

Thursday, August 14, 2014

The Almac Group is investing over $90.1 million and creating 348 jobs over the next five years. Almac Group provides services including drug discovery, diagnostics, R&D, the manufacture of active pharmaceutical ingredients, formulation development and clinical trials.

[Read More]

Almac expands Asia Pacific operations

Wednesday, March 12, 2014

Global CDMO Almac has expanded its clinical services and technologies capabilities in Asia. The company has established regional hubs in Singapore and Japan to better enable the industry’s growing need to conduct clinical trials in Asia and manage global trials from the region. Local teams will design, implement and manage drug supply strategies and efficient technology solutions throughout the life of each study. 

[Read More]

Genomic Health, Almac collaborate on test to predict chemotherapy benefits

Wednesday, November 27, 2013

Genomic Health, a provider of genomic-based diagnostic tests, will exclusively license Almac Group’s technology and intellectual property to further develop, validate and subsequently commercialize a multi-gene test to predict benefit from DNA damage-based chemotherapy drugs, such as the commonly used anthracycline-based regimens, in breast cancer.  Such a test would be particularly useful for high-risk breast cancer patients who are eligible for chemotherapy based on their Oncotype DX score. 

[Read More]